Private Rounds: More funds

CW Group is looking to raise $100 million for CW Ventures III, which will invest in early-stage health care companies. As much as half of the money could go to biotechnology, "if you include the information-technology

Read the full 364 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE